Connection

Pål Aukrust to Ventricular Function, Left

Back to Details
This is a "connection" page, showing publications Pål Aukrust has written about Ventricular Function, Left.
Pål Aukrust
Connection Strength
0.583
Ventricular Function, Left
  1. The prediction of adverse cardiac remodelling following myocardial infarction: defining the need for a dynamic multimarker approach. Heart. 2012 Aug; 98(15):1112-3.
    View in: PubMed
    Score: 0.252
  2. Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial. ESC Heart Fail. 2018 10; 5(5):977-984.
    View in: PubMed
    Score: 0.096
  3. The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy. J Cardiovasc Transl Res. 2017 Aug; 10(4):401-410.
    View in: PubMed
    Score: 0.088
  4. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. PLoS One. 2017; 12(3):e0173034.
    View in: PubMed
    Score: 0.087
  5. [Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]. Tidsskr Nor Laegeforen. 2001 Jun 20; 121(16):1902-7.
    View in: PubMed
    Score: 0.029
  6. The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. PLoS One. 2014; 9(2):e89732.
    View in: PubMed
    Score: 0.018
  7. Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure. Clin Sci (Lond). 2011 Aug; 121(3):119-27.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.